Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Objective: Perioperative intraperitoneal chemotherapy after cytoreductive surgery is used in ovarian cancer treatment. The purpose of the study is the evaluation of the effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as upfront treatment in advanced ovarian cancer. Materials and Methods: Prospective observational study of 166 women that underwent 189 cytoreductive operations for advanced ovarian cancer and in 55 of them HIPEC was used as upfront treatment. Clinical indicators were correlated to morbidity, hospital mortality, survival, and recurrences. Results: HIPEC as upfront treatment was found to be related to recurrence (p = 0.001) but not to overall survival. The prognostic variables of survival were the performance status, the completeness of cytoreduction, and the use of HIPEC (p < 0.001). The prognostic variables of recurrence were the degree of differentiation, and systemic chemotherapy (p = 0.05). Conclusion: HIPEC as upfront treatment after cytoreductive surgery may be another promising treatment strategy in patients with epithelial ovarian cancer. Prospective randomized trials are required.
Authors and Affiliations
A. A. K. Tentes, T. B. Palaskas, K. Stamou, C. E. Stoforos, N. Pallas, C. Karamveri, D. Kyziridis, V. Kyriakopoulos
Keywords
Related Articles
- EP ID EP626319
- DOI 10.12892/ejgo4248.2019
- Views 76
- Downloads 0
Resource utilisation and cost of cervical cancer and dysplasia in Croatia
Purpose of investigation: To analyse resource utilisation and costs due to cervical cancer and dysplasia in Croatia. Materials and Methods: Patients diagnosed with cervical cancer were identified from the Croatian Nation...
Risk of cervical cancer and squamous intraepithelial lesions according to human papillomavirus high-risk serotypes detected by qualitative real-time in vitro PCR
Purpose of investigation: To establish the relationship between high-risk human papillomavirus (hrHPV) serotypes and the odds of developing cervical intraepithelial lesions. Material and Methods: Retrospective cohort stu...
Immunohistochemical analysis of IQGAP2 in ovarian cancer
IQ motif-containing GTPase-activating protein 2 (IQGAP2) was regarded as a tumor suppressor in some cancers, but its expression pattern in various histological subtypes of ovarian cancer has not been investigated. Immuno...
Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer
Objective: Perioperative intraperitoneal chemotherapy after cytoreductive surgery is used in ovarian cancer treatment. The purpose of the study is the evaluation of the effect of hyperthermic intraoperative intraperitone...
Plasma fibrinogen, CRP, and hs-CRP levels in patients with benign and borderline ovarian tumours
Objective: Ovarian tumours can be classified as benign, borderline or malignant lesions. The purpose of this study was to assess, inter alia, fibrinogen concentration, and the (C-reactive proteins) and high-sensitivity C...